Pharming Group Investor Presentation — May 2024

Document content

NASDAQ: PHAR | EURONEXT Amsterdam: PHARMPharming Group N.V.

First quarter 2024 financial

results and business update

May 8, 2024SPEAKERS

Chief Executive Officer

Chief Commercial OfficerAnurag Relan, MD

Chief Medical OfficerJeroen Wakkerman

Chief Financial Officer

Forward -looking statements

This presentation may contain forward -looking statements . Forward -looking statements are statements of future expectations that are

based on management’s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause

actual results, performance, or events to differ materially from those expressed or implied in these statements . These forward -looking

statements are identified by their use of terms and phrases such as “aim”, “ambition”, ‘‘anticipate’’, ‘‘believe’’, ‘‘could’’, ‘‘estimate’’,

‘‘expect’’, ‘‘goals’’, ‘‘intend’’, ‘‘may’’, “milestones”, ‘‘objectives’’, ‘‘outlook’’, ‘‘plan’’, ‘‘probably’’, ‘‘project’’, ‘‘risks’’, “schedule”, ‘‘seek’’,

‘‘should’’, ‘‘target’’, ‘‘will’’ and similar terms and phrases . Examples of forward -looking statements may include statements with respect to

timing and progress of Pharming's preclinical studies and clinical trials of its product candidates, Pharming's clinical and commercial

prospects, and Pharming's expectations regarding its projected working capital requirements and cash resources, which statements are

subject to a number of risks, uncertainties and assumptions, including, but not limited to the scope, progress and expansion of Pharming's